Explore the vast range of titles available.

Sonic Hedgehog signaling is critical for breast morphogenesis and cancer. The present study was conducted to explore the influence of SHH/GLI1 axis on epithelial mesenchymal transition and invasion in breast cancer cells. SHH/GLI1 positive samples demonstrated high expression of Snail and Vimentin with relatively low expression of E-cadherin. Overexpression of Vimentin and Snail in SHH/GLI1 positive patients was also associated with poor overall survival. Interestingly, GANT61 (GLI1 inhibitor) exposure significantly reduced cell viability and induced apoptosis at 10 µM. Suppression of Hedgehog pathway either by CRISPR mediated SHH knock out or GANT61 altered regulation of EMT markers in breast cancer cells. Moreover, in-activation of SHH/GLI1 axis also significantly restricted cell migration and invasiveness. These findings suggest that targeting SHH/GLI1 axis alters expression of EMT markers and abrogates neoplastic invasion in breast cancer cells.

The cGAS-STING signaling pathway has emerged as a promising target for immunotherapy development. Here, we introduce a light-sensitive optogenetic device for control of the cGAS/STING signaling to conditionally modulate innate immunity, called ‘light-inducible SMOC-like repeats’ (LiSmore). We demonstrate that photo-activated LiSmore boosts dendritic cell (DC) maturation and antigen presentation with high spatiotemporal precision. This non-invasive approach photo-sensitizes cytotoxic T lymphocytes to engage tumor antigens, leading to a sustained antitumor immune response. When combined with an immune checkpoint blocker (ICB), LiSmore improves antitumor efficacy in an immunosuppressive lung cancer model that is otherwise unresponsive to conventional ICB treatment. Additionally, LiSmore exhibits an abscopal effect by effectively suppressing tumor growth in a distal site in a bilateral mouse model of melanoma. Collectively, our findings establish the potential of targeted optogenetic activation of the STING signaling pathway for remote immunomodulation in mice. Optogenetics makes use of light-sensitive proteins to control biological processes using light. Here, the authors present an optogenetic system that regulates the cGAS/STING pathway remotely and demonstrate its efficacy in murine tumour models.

Alterations in free Ca2+ concentration, known as Ca2+ signals,1 play a vital role in regulating a wide array of physiological and pathological processes, including synaptic transmission, muscle contraction, cytokine secretion, gene transcription, cell growth, and cell death.2 Abnormal Ca2+ signalling has been implicated in various human disorders such as cancer, immunodeficiency, myocardial hypertrophy, and neurodegenerative diseases.3 Ca2+ signals possess the capacity to convey crucial information through three-dimensional variations in amplitude, temporal and spatial distribution (Figure 1A). Over the past four decades, considerable efforts have been devoted to developing biosensors and actuators aimed at interrogating these three fundamental properties of Ca2+ signals.4 Given their facile genetic manipulation and tunable sensitivity, genetically encoded Ca2+ indicators (GECIs) have gained widespread popularity for tracking intracellular Ca2+ signals or Ca2+-modulated cell activities.5 A typical GECI comprises a Ca2+-sensing moiety (sensor) and a fluorescence reporting module (reporter). Through several generations of evolution over the past two decades, GECIs have shown significantly enhanced sensitivity and diversified kinetics.6 Among them, the latest jGCaMP8f exhibits an impressive activation half-time of 2 ms, which enables better decoding of fast-acting Ca2+ signals seen in excitable cells including neurons and cardiomyocytes.7 Nonetheless, the advancements in their intracellular dynamics, particularly the capacity of GECIs to resolve subtle Ca2+ signal amplitudes, have progressed at a comparatively slower pace since the inception of the GCaMP6 series.

Prostate cancer (PCa) is the most common male cancer and the second leading cause of cancer death in men. Androgen deprivation therapy (ADT) has been widely used as the first-line treatment for PCa. However, most PCa will progress to castration-resistant PCa (CRPC) that resists ADT 1 to 3 years after the treatment. Steroidogenesis from cholesterol is one of the mechanisms leading to ADT resistance. In PCa cells, low-density lipoprotein (LDL) mediated uptake is the major venue to acquire cholesterol. However, the mechanism of regulating this process is not fully understood. Fibroblast growth factor receptor 1 (FGFR1) is a receptor tyrosine kinase (RTK) that is ectopically expressed in PCa cells and promotes PCa progression by activating downstream signaling pathways. To comprehensively determine the roles of FGFR1 in PCa, we generated FGFR1-null DU145 cells and compared the transcriptomes of FGFR1-null and wild-type cells. We found that ablation of FGFR1 reduced the expression of genes promoting LDL uptake and de novo synthesis of cholesterol, thereby reducing the overall cholesterol pool in PCa cells. Detailed mechanistic studies further revealed that FGFR1 boosted the activation of sterol regulatory element-binding protein 2 (SREBP2) through ERK-dependent phosphorylation and cleavage, which, in turn, increased the expression of low-density lipoprotein receptor (LDLR) and enzymes involved in de novo cholesterol synthesis. Furthermore, in silico analyses demonstrated that high expression of FGFR1 was associated with high LDLR expression and clinicopathological features in PCa. Collectively, our data unveiled a previously unrecognized therapeutic avenue for CRPC by targeting FGFR1-driven cholesterol uptake and de novo synthesis.

Endoplasmic reticulum (ER) calcium (Ca2+) homeostasis is essential for maintaining normal cellular physiological functions. Its disturbance is strongly linked to the onset and progression of human diseases, including cancer, developmental defects, and neurodegenerative disorders. The lack of sensitive ratiometric ER Ca2+ indicators, nevertheless, hinders systematic investigation of ER Ca2+ modulators and the underlying mechanisms. Capitalizing on two ultra-sensitive ER Ca2+ indicators and CRISPR-based genome-wide screening, we identified a set of proteins capable of reducing the ER Ca2+ content. Further comparative analysis and qPCR validation pinpointed adenylate cyclase 9 (AC9), which is upregulated during neuronal differentiation, as a key ER-Ca2+-reducing regulator. Mechanistically, AC9-mediated production of cAMP is not essential for its ability to reduce ER Ca2+ content. Instead, AC9 inhibits store operated calcium entry (SOCE) by acting on Orai1, ultimately causing attenuation of ER Ca2+ level. More physiologically relevant, upregulation of AC9 in neurons is essential for reducing ER Ca2+ levels during Drosophila brain development. Collectively, this study lays a solid groundwork for further in-depth exploration of the regulatory mechanisms dictating ER Ca2+ homeostasis during neuronal differentiation and brain development.Competing Interest StatementThe authors have declared no competing interest.

Endoplasmic reticulum (ER) calcium (Ca2+) homeostasis is essential for maintaining normal cellular physiological functions. Its disturbance is strongly linked to the onset and progression of human diseases, including cancer, developmental defects, and neurodegenerative disorders. The lack of sensitive ratiometric ER Ca2+ indicators, nevertheless, hinders systematic investigation of ER Ca2+ modulators and the underlying mechanisms. Capitalizing on two ultra-sensitive ER Ca2+ indicators and CRISPR-based genome-wide screening, we identified a set of proteins capable of reducing the ER Ca2+ content. Further comparative analysis and qPCR validation pinpointed adenylate cyclase 9 (AC9), which is upregulated during neuronal differentiation, as a key ER-Ca2+-reducing regulator. Mechanistically, AC9-mediated production of cAMP is not essential for its ability to reduce ER Ca2+ content. Instead, AC9 inhibits store operated calcium entry (SOCE) by acting on Orai1, ultimately causing attenuation of ER Ca2+ level. More physiologically relevant, upregulation of AC9 in neurons is essential for reducing ER Ca2+ levels during Drosophila brain development. Collectively, this study lays a solid groundwork for further in-depth exploration of the regulatory mechanisms dictating ER Ca2+ homeostasis during neuronal differentiation and brain development.

Background Endometriosis (EMs) is an enigmatic disease of yet-unknown pathogenesis. Disulfidptosis, a novel identified form of programmed cell death resulting from disulfide stress, stands a chance of treating diverse ailments. However, the potential roles of disulfidptosis-related genes (DRGs) in EMs remain elusive. This study aims to thoroughly explore the key disulfidptosis genes involved in EMs, and probe novel diagnostic markers and candidate therapeutic compounds from the aspect of disulfidptosis based on bioinformatics analysis, machine learning, and animal experiments. Results Enrichment analysis on key module genes and differentially expressed genes (DEGs) of eutopic and ectopic endometrial tissues in EMs suggested that EMs was closely related to disulfidptosis. And then, we obtained 20 and 16 disulfidptosis-related DEGs in eutopic and ectopic endometrial tissue, respectively. The protein-protein interaction (PPI) network revealed complex interactions between genes, and screened nine and ten hub genes in eutopic and ectopic endometrial tissue, respectively. Furthermore, immune infiltration analysis uncovered distinct differences in the immunocyte, human leukocyte antigen (HLA) gene set, and immune checkpoints in the eutopic and ectopic endometrial tissues when compared with health control. Besides, the hub genes mentioned above showed a close correlation with the immune microenvironment of EMs. Furthermore, four machine learning algorithms were applied to screen signature genes in eutopic and ectopic endometrial tissue, including the binary logistic regression (BLR), the least absolute shrinkage and selection operator (LASSO), the support vector machine-recursive feature elimination (SVM-RFE), and the extreme gradient boosting (XGBoost). Model training and hyperparameter tuning were implemented on 80% of the data using a ten-fold cross-validation method, and tested in the testing sets which determined the excellent diagnostic performance of these models by six indicators (Sensitivity, Specificity, Positive Predictive Value, Negative Predictive Value, Accuracy, and Area Under Curve). And seven eutopic signature genes (ACTB, GYS1, IQGAP1, MYH10, NUBPL, SLC7A11, TLN1) and five ectopic signature genes (CAPZB, CD2AP, MYH10, OXSM, PDLIM1) were finally identified based on machine learning. The independent validation dataset also showed high accuracy of the signature genes (IQGAP1, SLC7A11, CD2AP, MYH10, PDLIM1) in predicting EMs. Moreover, we screened 12 specific compounds for EMs based on ectopic signature genes and the pharmacological impact of tretinoin on signature genes was further verified in the ectopic lesion in the EMs murine model. Conclusion This study verified a close association between disulfidptosis and EMs based on bioinformatics analysis, machine learning, and animal experiments. Further investigation on the biological mechanism of disulfidptosis in EMs is anticipated to yield novel advancements for searching for potential diagnostic biomarkers and revolutionary therapeutic approaches in EMs.

Water-soluble organic carbon (WSOC) accounts for a large proportion of aerosols and plays a critical role in various atmospheric chemical processes. In order to investigate the primary sources and secondary production of WSOC in downtown Beijing, day and night fine particulate matter (PM2.5) samples in January (winter), April (spring), July (summer) and October (autumn) 2017 were collected and analyzed for WSOC and organic tracers in this study. WSOC was dominated by its moderately hydrophilic fraction and showed the highest concentration in January and comparable levels in April, July and October 2017. Some typical organic tracers were chosen to evaluate the emission strength and secondary formation of WSOC. Seasonal variation of the organic tracers suggested significantly enhanced formation of anthropogenic secondary organic aerosols (SOAs) during the sampling period in winter and obviously elevated biogenic SOA formation during the sampling period in summer. These organic tracers were applied into a positive matrix factorization (PMF) model to calculate the source contributions of WSOC as well as its moderately and strongly hydrophilic portions. The secondary sources contributed more than 50 % to WSOC, with higher contributions during the sampling periods in summer (75.1 %) and winter (67.4 %), and the largest contributor was aromatic SOC. In addition, source apportionment results under different pollution levels suggested that controlling biomass burning and aromatic precursors would be effective to reduce WSOC during the haze episodes in cold seasons. The impact factors for the formation of different SOA tracers and total secondary organic carbon (SOC) as well as moderately and strongly hydrophilic SOC were also investigated. The acid-catalyzed heterogeneous or aqueous-phase oxidation appeared to dominate in the SOC formation during the sampling period in winter, while the photochemical oxidation played a more critical role during the sampling period in summer. Moreover, photooxidation played a more critical role in the formation of moderately hydrophilic SOC, while the heterogeneous or aqueous-phase reactions had more vital effects on the formation of strongly hydrophilic SOC.

Despite recent improvements in the comprehensive therapy of malignancy, metastatic colorectal cancer (mCRC) continues to have a poor prognosis. Notably, 5% of mCRC cases harbor Erb-B2 receptor tyrosine kinase 2 (ERBB2) alterations. ERBB2, commonly referred to as human epidermal growth factor receptor 2, is a member of the human epidermal growth factor receptor family of protein tyrosine kinases. In addition to being a recognized therapeutic target in the treatment of gastric and breast malignancies, it is considered crucial in the management of CRC. In this review, we describe the molecular biology of ERBB2 from the perspective of biomarkers for mCRC-targeted therapy, including receptor structures, signaling pathways, gene alterations, and their detection methods. We also discuss the relationship between ERBB2 aberrations and the underlying mechanisms of resistance to anti-EGFR therapy and immunotherapy tolerance in these patients with a focus on novel targeted therapeutics and ongoing clinical trials. This may aid the development of a new standard of care in patients with ERBB2-positive mCRC.

Diabetic nephropathy (DN) is a leading cause of end-stage kidney disease (ESKD), with renal fibrosis as a key pathological hallmark. However, the cellular and molecular drivers of fibrosis remain incompletely defined. Here, we employed single-cell RNA sequencing (scRNA-seq) to delineate pro-fibrotic cell subsets and their key regulatory factors in human DN kidneys, providing a higher-resolution view compared to previous fibrosis-related scRNA-seq studies. Publicly available scRNA-seq datasets from human DN and control kidneys were analyzed to identify fibrosis-associated fibroblast subsets. A Tmsb10-high fibroblast population was prioritized. Functional validation was performed through Tmsb10 knockdown in NIH-3T3 fibroblasts and in a diabetic mouse model, followed by assessment of fibrosis markers, extracellular matrix (ECM) deposition, and TGF-β/SMAD signaling. scRNA-seq revealed a significant expansion of Tmsb10-high fibroblasts in DN kidneys, exhibiting strong enrichment of ECM-related and TGF-β/SMAD-responsive genes. Tmsb10 knockdown reduced Fn1, Col1a1, and α-Sma expression by approximately 50-70% and markedly attenuated ECM accumulation in vivo. Mechanistically, TMSB10 deficiency suppressed phosphorylation of SMAD2/3, mitigating fibroblast activation and matrix deposition. This study identifies TMSB10 as a novel fibroblast-specific regulator of renal fibrosis in DN, acting through the TGF-β/SMAD pathway. These findings expand current understanding of fibroblast heterogeneity and highlight TMSB10 as a potential therapeutic target for DN and other fibrotic diseases. Limitations include validation in a limited sample size and the use of murine fibroblast models, warranting further confirmation in human primary cells.